Early research (Phase 1)Ended earlyNCT03579888
What this trial is testing
CD19-Specific T Cells Post AlloSCT
Who this might be right for
B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A RearrangedRecurrent B Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+14 more
M.D. Anderson Cancer Center 4